TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Team Select Home Care says its CareSight AI platform now covers its full patient census through respiratory, cardiac and infection-detection models. Company data shared with Home Health Care News show a 14.9% year-over-year decrease in hospitalization rates from April through August 2026; the figures have not been independently verified in the material provided.
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census, and company data show a 14.9% year-over-year drop in hospitalization rates from April through August 2026. The Phoenix-based provider shared the five-month comparison with Home Health Care News, but the figures are company-reported and the material does not describe an independent evaluation.
CareSight uses machine-learning models built from more than a decade of Team Select patient data. The platform monitors up to eight vital signs in real time, along with nurse notes and changes in a patient’s condition, to flag patterns that may signal clinical decline. Team Select serves medically complex children and seniors receiving care at home and operates in 16 states.
The provider introduced the system in 2025, beginning with a model for respiratory patients. It later added a cardiac model and an infection-detection model. According to company president and CEO Fred Johnson, the respiratory model took three years to develop, the cardiac model six months, and the infection model 90 days. Team Select says every patient is now covered by at least one of the three models.
The reported 14.9% decline compares hospitalization rates in April-August 2026 with the same months in 2025. Johnson told Home Health Care News that the improvement followed deployment of the three models. The report does not provide the underlying patient counts, statistical analysis or a detailed breakdown by diagnosis, so the percentage should be read as a company-reported outcome rather than proof that the software alone caused the change.
AI Data Enters Payer Negotiations
The reported change could support Team Select’s effort to negotiate value-based contracts, in which payment is tied in part to outcomes or costs rather than only service volume. Johnson said the company hopes to use hospitalization and total-cost-of-care measures to make a case for additional payer agreements, especially when standard fee-for-service rate increases are difficult to secure.
For patients and their families, the company’s stated goal is to identify deterioration early enough for clinicians to respond while patients remain at home. A lower hospitalization rate may be relevant to that goal, but the figures supplied do not establish whether patients experienced fewer emergency visits, better health outcomes overall, or changes in access to needed hospital care. Those outcomes would require more detailed evidence.
CareSight may also give the provider a way to distinguish its operations in a competitive home-care market. That distinction matters to payers only if performance measures are reliable, comparable and sustained. The company’s reported results may inform those discussions, but the material does not say that new contracts have been signed because of the platform.
patient vital signs monitoring device
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Three Models Built From Patient Data
Team Select first concentrated on respiratory patients after reviewing which diagnoses and comorbidities accounted for hospitalizations, Johnson said. The company selected that group because it had experience providing high-acuity respiratory care. After developing the initial model, it moved to cardiac patients; Johnson said the cardiac system benefited from the data preparation and learning completed during the first effort.
As the platform expanded, the company also adjusted how it handled alerts. Johnson said the initial system produced too many false positives, including flags based on readings outside general parameters that were normal for an individual patient. Team Select added a patient-specific model that compares measurements with a person’s historical baseline, which the company says helped reduce unnecessary alerts to clinicians.
Before CareSight launched, a seven-state Medicaid claims study commissioned by Team Select found a monthly 30-day hospitalization rate of 3% to 8% for the company, Johnson said, compared with an industry average he described as 10% to 20% per month. The source material does not provide the study itself or its methods. These earlier figures are distinct from the new 14.9% year-over-year comparison and should not be treated as an independent validation of the newer result.
““I knew that if we could do this, not only would it be a long-lasting competitive advantage … [it] would significantly decrease those hospitalizations even further.””
— Fred Johnson, Team Select president and CEO, as quoted by Home Health Care News
AI health monitoring system for home care
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Independent Validation Still Missing
The source material does not specify the number of patients included in the April-August comparison, the absolute hospitalization rates in each year, or the statistical methods used. It also does not identify whether the patient population or mix of diagnoses changed between periods. Without those details, readers cannot assess how much the reported decline reflects CareSight, other care changes, or differences between the compared groups.
No independent analysis or payer confirmation is cited in the material. It is also unclear whether the 14.9% figure refers to a relative decrease in the rate or another calculation, and whether reductions were similar across the three model groups. Team Select’s earlier Medicaid comparison is described by Johnson, but the underlying study and its methodology are not included.
remote patient monitoring equipment
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Diabetes Model Is in Development
Team Select is building a fourth CareSight model focused on diabetes, according to the report. The company has not provided a launch date, described the model’s intended measures, or said how it will assess performance after deployment.
The provider also plans to redevelop payer scorecards. Johnson said those could show payers patient-specific Net Promoter Scores, hospitalization rates and emergency department visit ratios, with comparisons to industry averages. The timing and methodology for those scorecards have not been specified. Further outcome reporting, including clearer details on patient numbers, baseline rates and independent review, would help assess whether the hospitalization trend continues.
hospitalization risk prediction tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did Team Select report?
Team Select said its CareSight AI platform now covers all of its patients and that hospitalization rates fell 14.9% year over year from April through August 2026. The figures were provided by the company to Home Health Care News.
What does CareSight monitor?
The platform uses models for respiratory conditions, cardiac conditions and infection risk. It monitors up to eight vital signs, nurse notes and changes in condition, according to the report.
Has the hospitalization decline been independently verified?
The source material does not cite an independent review. It gives company-supplied data but does not provide patient counts, detailed methods or a statistical analysis.
What is Team Select planning next?
The company is developing a diabetes-focused fourth model and redeveloping payer scorecards with measures such as hospitalization and emergency department visit ratios. No schedule for either effort is given.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
